
Sophia S. Chen
Examiner (ID: 12715, Phone: (571)272-2133 , Office: P/2852 )
| Most Active Art Unit | 2852 |
| Art Unit(s) | 2809, 2105, 2852 |
| Total Applications | 3640 |
| Issued Applications | 3462 |
| Pending Applications | 93 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10381920
[patent_doc_number] => 20150266928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'METHOD OF PROTEIN EXTRACTION FROM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/598148
[patent_app_country] => US
[patent_app_date] => 2015-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11006
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598148
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598148 | Method of protein extraction from cells | Jan 14, 2015 | Issued |
Array
(
[id] => 11198353
[patent_doc_number] => 09428556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Compositions and methods for the treatment or prevention of hepatitis B virus infection'
[patent_app_type] => utility
[patent_app_number] => 14/591592
[patent_app_country] => US
[patent_app_date] => 2015-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 42
[patent_no_of_words] => 96366
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14591592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/591592 | Compositions and methods for the treatment or prevention of hepatitis B virus infection | Jan 6, 2015 | Issued |
Array
(
[id] => 10458032
[patent_doc_number] => 20150343047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL DYSPLASIA'
[patent_app_type] => utility
[patent_app_number] => 14/579819
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 37868
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579819
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/579819 | COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL DYSPLASIA | Dec 21, 2014 | Abandoned |
Array
(
[id] => 10273935
[patent_doc_number] => 20150158933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'HIV Antigens and Antibodies and Compositions, Uses and Methods Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/564075
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 64516
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564075
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/564075 | HIV antigens and antibodies and compositions, uses and methods thereof | Dec 7, 2014 | Issued |
Array
(
[id] => 10201557
[patent_doc_number] => 20150086546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/559787
[patent_app_country] => US
[patent_app_date] => 2014-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 35175
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14559787
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/559787 | HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR | Dec 2, 2014 | Abandoned |
Array
(
[id] => 10262787
[patent_doc_number] => 20150147784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'Reagents and Methods for Detecting Influenza Virus Proteins'
[patent_app_type] => utility
[patent_app_number] => 14/556415
[patent_app_country] => US
[patent_app_date] => 2014-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6889
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14556415
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/556415 | Reagents and methods for detecting influenza virus proteins | Nov 30, 2014 | Issued |
Array
(
[id] => 17015395
[patent_doc_number] => 11085022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/512726
[patent_app_country] => US
[patent_app_date] => 2014-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 19
[patent_no_of_words] => 9088
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512726 | Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof | Nov 26, 2014 | Issued |
Array
(
[id] => 12099365
[patent_doc_number] => 09856453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject'
[patent_app_type] => utility
[patent_app_number] => 14/549296
[patent_app_country] => US
[patent_app_date] => 2014-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 46
[patent_no_of_words] => 43933
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549296
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/549296 | Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject | Nov 19, 2014 | Issued |
Array
(
[id] => 16697903
[patent_doc_number] => 10948494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Methods for enumeration of rare cells
[patent_app_type] => utility
[patent_app_number] => 15/033995
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8542
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/033995 | Methods for enumeration of rare cells | Nov 6, 2014 | Issued |
Array
(
[id] => 10290951
[patent_doc_number] => 20150175950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'METHOD AND APPARATUS FOR VIRUS AND VACCINE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 14/528007
[patent_app_country] => US
[patent_app_date] => 2014-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 26252
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14528007
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/528007 | Method and apparatus for virus and vaccine production | Oct 29, 2014 | Issued |
Array
(
[id] => 10347950
[patent_doc_number] => 20150232955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'Method for Measuring Cell-Free Virus Particles From Dried Blood Spots'
[patent_app_type] => utility
[patent_app_number] => 14/518150
[patent_app_country] => US
[patent_app_date] => 2014-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7198
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518150
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/518150 | Method for measuring cell-free virus particles from dried blood spots | Oct 19, 2014 | Issued |
Array
(
[id] => 9838526
[patent_doc_number] => 20150030607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'INFLUENZA HEMAGGLUTININ-SPECIFIC MONOCLONAL ANTIBODIES FOR PREVENTING AND TREATING INFLUENZA VIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/511013
[patent_app_country] => US
[patent_app_date] => 2014-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7254
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511013 | Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection | Oct 8, 2014 | Issued |
Array
(
[id] => 10299160
[patent_doc_number] => 20150184159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'USE OF COX-3 BINDING MOLECULES FOR MODULATING AUTOPHAGY'
[patent_app_type] => utility
[patent_app_number] => 14/505338
[patent_app_country] => US
[patent_app_date] => 2014-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 43211
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 68
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/505338 | USE OF COX-3 BINDING MOLECULES FOR MODULATING AUTOPHAGY | Oct 1, 2014 | Abandoned |
Array
(
[id] => 10225835
[patent_doc_number] => 20150110828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'YEAST-BASED THERAPEUTIC FOR CHRONIC HEPATITIS B INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/494235
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 96262
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14494235
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/494235 | Yeast-based therapeutic for chronic hepatitis B infection | Sep 22, 2014 | Issued |
Array
(
[id] => 11031574
[patent_doc_number] => 20160228531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'TREATMENT OF HEPATITIS D VIRUS INFECTIONS BY REDIRECTION OF T CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/022896
[patent_app_country] => US
[patent_app_date] => 2014-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2985
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022896
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022896 | TREATMENT OF HEPATITIS D VIRUS INFECTIONS BY REDIRECTION OF T CELLS | Sep 16, 2014 | Abandoned |
Array
(
[id] => 15358013
[patent_doc_number] => 10527618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Sample processing method for influenza virus immunoassay, and immunoassay method
[patent_app_type] => utility
[patent_app_number] => 14/917632
[patent_app_country] => US
[patent_app_date] => 2014-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6039
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917632
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917632 | Sample processing method for influenza virus immunoassay, and immunoassay method | Sep 9, 2014 | Issued |
Array
(
[id] => 16229311
[patent_doc_number] => 10736840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Thermally stable vaccine formulations and microneedles
[patent_app_type] => utility
[patent_app_number] => 14/916417
[patent_app_country] => US
[patent_app_date] => 2014-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 9093
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916417
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916417 | Thermally stable vaccine formulations and microneedles | Sep 2, 2014 | Issued |
Array
(
[id] => 10996377
[patent_doc_number] => 20160193324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'METHODS OF IMMUNIZATION WITH VARICELLA ZOSTER VIRUS ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 14/916458
[patent_app_country] => US
[patent_app_date] => 2014-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11211
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916458 | Methods of immunization with varicella zoster virus antigen | Sep 1, 2014 | Issued |
Array
(
[id] => 9910492
[patent_doc_number] => 20150065694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'Preassembled hybrid nanocluster plasmonic resonator for immunological detection and serotyping of virus and microbes'
[patent_app_type] => utility
[patent_app_number] => 14/472516
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4696
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472516
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/472516 | Preassembled hybrid nanocluster plasmonic resonator for immunological detection and serotyping of virus and microbes | Aug 28, 2014 | Abandoned |
Array
(
[id] => 11003850
[patent_doc_number] => 20160200799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'ANTI-INFLUENZA VIRUS NEUTRALIZING ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 14/913613
[patent_app_country] => US
[patent_app_date] => 2014-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19816
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913613
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913613 | ANTI-INFLUENZA VIRUS NEUTRALIZING ANTIBODY | Aug 19, 2014 | Abandoned |